R. Jitschin

发表

N‐glycosylation controls inflammatory licensing‐triggered PD‐L1 upregulation in human mesenchymal stromal cells

V. Strauch, D. Saul, M. Berisha, 2020, Stem cells.

CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.

P. Oefner, A. Mackensen, D. Mougiakakos, 2014, Blood.

Vitamin D–dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma

A. Mackensen, D. Mougiakakos, R. Jitschin, 2015, Science Translational Medicine.

Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation

D. Mougiakakos, R. Jitschin, K. Le Blanc, 2013, Oncoimmunology.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome

R. Sandberg, Tina Koestler, D. Mougiakakos, 2015, Stem cells translational medicine.

Mesenchymal Stromal Cells Disrupt mTOR‐Signaling and Aerobic Glycolysis During T‐Cell Activation

D. Saul, A. Mackensen, D. Mougiakakos, 2016, Stem cells.

The impact of inﬂammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

D. Mougiakakos, R. Jitschin, R. Kiessling, 2011 .

Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress.

D. Mougiakakos, R. Jitschin, R. Kiessling, 2011, Blood.

Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling

D. Saul, A. Mackensen, D. Mougiakakos, 2020, Cancer Research.

Contact-Dependent Depletion of Hydrogen Peroxide by Catalase Is a Novel Mechanism of Myeloid-Derived Suppressor Cell Induction Operating in Human Hepatic Stellate Cells

C. Weston, S. Curbishley, D. Adams, 2015, The Journal of Immunology.

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

D. Mougiakakos, R. Jitschin, P. Ljungman, 2013, Leukemia.

CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D

A. Mackensen, D. Mougiakakos, R. Jitschin, 2017, Leukemia.

Lenalidomide Enhances MOR202 Dependent Macrophage-Mediated Effector Functions Via the Vitamin D Pathway

M. Rehli, A. Mackensen, D. Mougiakakos, 2015 .

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome

R. Sandberg, Tina Koestler, D. Mougiakakos, 2015, Stem cells translational medicine.

Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses

John D Lambris, B. Nilsson, D. Mougiakakos, 2011, PloS one.

Crosstalk of human mesenchymal stromal cells with the cellular components of the immune system

R. Jitschin, 2013 .

Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling.

D. Saul, D. Mougiakakos, R. Jitschin, 2015, Blood.

CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis

D. Saul, A. Mackensen, D. Mougiakakos, 2016, Leukemia.

Alterations in the Cellular Immune Compartment of Patients Treated with Third‐Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation

D. Mougiakakos, R. Jitschin, R. Kiessling, 2013, Stem cells.

Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report

A. Mackensen, D. Mougiakakos, R. Jitschin, 2021, Journal for ImmunoTherapy of Cancer.

Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells.

B. Sander, D. Mougiakakos, R. Jitschin, 2012, Stem cells and development.

Impact of Nrf2 expression in reconstituting T-cells of allogeneic hematopoietic stem cell transplanted patients

A. Mackensen, D. Mougiakakos, R. Jitschin, 2020, Leukemia.

Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia.

D. Saul, A. Mackensen, D. Mougiakakos, 2014, Blood.

therapeutic targets in chronic lymphocytic leukemia Mitochondrial metabolism contributes to oxidative stress and reveals

D. Saul, A. Mackensen, D. Mougiakakos, 2014 .

Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation

A. Ekici, D. Saul, A. Mackensen, 2019, Leukemia.

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

D. Saul, A. Mackensen, D. Mougiakakos, 2018, Journal of Immunotherapy for Cancer.

The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia

D. Saul, A. Mackensen, D. Mougiakakos, 2017, Leukemia.

The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells.

D. Mougiakakos, R. Jitschin, R. Kiessling, 2011, Blood.

Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders.

R. Jitschin, H. Segerer, S. Modrow, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A novel immunoregulatory function of beta-2-microglobulin as a promoter of myeloid derived suppressor cell induction

D. Saul, A. Mackensen, D. Mougiakakos, 2019, Leukemia.

Oxidative DNA Damage in Reconstituting T-cells is Associated with Relapse and Inferior Survival Following Allo-SCT.

T. Dandekar, Chunguang Liang, A. Mackensen, 2022, Blood.

Stellate Cells Induction Operating in Human Hepatic of Myeloid-Derived Suppressor Cell Peroxide by Catalase Is a Novel Mechanism Contact-Dependent Depletion of Hydrogen

C. Weston, S. Curbishley, D. Adams, 2015 .

Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib

D. Mougiakakos, R. Jitschin, M. Metzler, 2023, Cancer Immunology, Immunotherapy.

Phenotypic and functional alterations of myeloid‐derived suppressor cells during the disease course of multiple sclerosis

D. Mougiakakos, R. Jitschin, K. Le Blanc, 2018, Immunology and cell biology.

Accumulation of T-cell-suppressive PD-L1high extracellular vesicles is associated with GvHD and might impact GvL efficacy

U. Schlötzer-Schrehardt, A. Mackensen, D. Mougiakakos, 2023, Journal for ImmunoTherapy of Cancer.